Nuclear Imaging Devices Market Demonstrates a Spectacular Growth by 2027
Market Highlights
The global nuclear
imaging devices market is expected to grow significantly over the
forecast period. It is anticipated that the market held a valuation of USD 2490
million in 2018 and is projected to register a CAGR of 5.2% over the forecast
period.
Get Sample Reports: https://www.marketresearchfuture.com/sample_request/8014
The increasing prevalence of cardiovascular
disorders is one of the key factors driving the nuclear imaging devices
market. As per the report published by the Centers for Disease Control and
Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least
one type of cardiovascular disease.
Various other factors such as the advancements in
radiotracers, acceptance of nuclear imaging devices in ambulatory settings,
increasing geriatric population, untapped emerging markets, rise in regulatory
approvals, and increasing investment on diagnostic imaging centers are also
expected to propel the growth of the market.
However, the high cost of the nuclear imaging device,
shorter half-life of radiopharmaceuticals can hamper market growth over
the forecast period.
Key Players
Some of the key players in the global nuclear imaging
devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical
Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH,
CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General
Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical
Systems, Inc., Segamicorp, and others.
Segmentation
The global nuclear imaging devices market is segmented based
on technology, application, end user, and region.
·
The global market for nuclear imaging
devices, by technology, is segmented into positron emission tomography
(PET), single photon emission computed tomography (SPECT), and planar
scintigraphy. The single-photon-emission computed tomography (SPECT) are
further classified as hybrid SPECT systems and standalone SPECT systems.
·
Based on application, the market is
segmented into oncology, cardiology, neurology, and others.
·
Based on end user, the market is
segmented into hospitals, diagnostic imaging centers, and others.
·
The diagnostic imaging centers segment is
expected to witness the fastest growth over the forecast period due to rising
adoption of nuclear imaging in diagnostic centers.
Regional Analysis
In the current scope of the study, the segments mentioned above
are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market in the Americas has
further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The European nuclear imaging devices market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The nuclear imaging devices market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The nuclear imaging devices market in the Middle East &
Africa has been segmented into the Middle East and Africa.
Access Report Details @ https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment